ValGenesis Collaborates with Biocon Biologics for Digital Validation Across Multiple Sites
News provided by
Share this article
Share this article
SAN FRANCISCO, Dec. 15, 2020 /PRNewswire/ -- ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that the Equipment Commissioning and Qualification (C&Q) process (validation life cycle) at Biocon Biologics has been digitized leveraging the power of ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system. Biocon Biologics, a subsidiary of Biocon, is an integrated 'pure play' biosimilars organization addressing patients' needs across the world, including developed markets like the U.S., Canada, EU and Australia, through its partners.